Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 13.89%
March 31, 2026 17.29%
December 31, 2025 17.30%
September 30, 2025 15.00%
June 30, 2025 9.35%
March 31, 2025 16.62%
December 31, 2024 16.61%
September 30, 2024 14.11%
June 30, 2024 15.79%
March 31, 2024 18.77%
December 31, 2023 17.50%
September 30, 2023 16.71%
June 30, 2023 15.45%
March 31, 2023 20.84%
December 31, 2022 28.20%
September 30, 2022 20.51%
June 30, 2022 21.67%
March 31, 2022 22.44%
December 31, 2021 21.94%
September 30, 2021 16.02%
June 30, 2021 23.54%
March 31, 2021 24.82%
December 31, 2020 18.36%
September 30, 2020 15.02%
June 30, 2020 17.50%
Date Value
March 31, 2020 13.70%
December 31, 2019 16.29%
September 30, 2019 14.41%
June 30, 2019 15.22%
March 31, 2019 7.87%
December 31, 2018 14.85%
September 30, 2018 13.68%
June 30, 2018 13.53%
March 31, 2018 12.07%
December 31, 2017 16.84%
September 30, 2017 12.63%
June 30, 2017 12.36%
March 31, 2017 11.50%
December 31, 2016 16.29%
September 30, 2016 9.74%
June 30, 2016 9.85%
March 31, 2016 14.93%
December 31, 2015 12.49%
September 30, 2015 11.74%
June 30, 2015 13.57%
March 31, 2015 11.69%
December 31, 2014 12.21%
September 30, 2014 13.97%
June 30, 2014 13.63%
March 31, 2014 12.43%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 14.52%
Agilent Technologies, Inc. 19.28%
Illumina, Inc. 17.83%
Revvity, Inc. 7.33%
Bio-Rad Laboratories, Inc. 57.05%